HEADER PROTEIN BINDING 14-JUL-21 7P5P TITLE PYRAZOLE CARBOXYLIC ACID INHIBITORS OF KEAP1:NRF2 INTERACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYTOSOLIC INHIBITOR OF NRF2,INRF2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: KEAP1, INRF2, KIAA0132; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PROTEIN UBIQUITINATION, PROTEIN-PROTEIN INTERACTION, OXIDATIVE KEYWDS 2 STRESS, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR T.G.DAVIES REVDAT 2 24-NOV-21 7P5P 1 JRNL REVDAT 1 17-NOV-21 7P5P 0 JRNL AUTH D.NORTON,W.G.BONNETTE,J.F.CALLAHAN,M.G.CARR, JRNL AUTH 2 C.M.GRIFFITHS-JONES,T.D.HEIGHTMAN,J.K.KERNS,H.NIE,S.J.RICH, JRNL AUTH 3 C.RICHARDSON,W.RUMSEY,Y.SANCHEZ,M.L.VERDONK,H.M.G.WILLEMS, JRNL AUTH 4 W.E.WIXTED,L.WOLFE 3RD,A.J.WOOLFORD,Z.WU,T.G.DAVIES JRNL TITL FRAGMENT-GUIDED DISCOVERY OF PYRAZOLE CARBOXYLIC ACID JRNL TITL 2 INHIBITORS OF THE KELCH-LIKE ECH-ASSOCIATED PROTEIN 1: JRNL TITL 3 NUCLEAR FACTOR ERYTHROID 2 RELATED FACTOR 2 (KEAP1:NRF2) JRNL TITL 4 PROTEIN-PROTEIN INTERACTION. JRNL REF J.MED.CHEM. V. 64 15949 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34705450 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01351 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0222 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 25382 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.154 REMARK 3 R VALUE (WORKING SET) : 0.153 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1349 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.89 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1237 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.2640 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 335 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.42000 REMARK 3 B22 (A**2) : -0.42000 REMARK 3 B33 (A**2) : 1.35000 REMARK 3 B12 (A**2) : -0.21000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.124 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.117 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.130 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2326 ; 0.009 ; 0.015 REMARK 3 BOND LENGTHS OTHERS (A): 1944 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3174 ; 1.333 ; 1.750 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4558 ; 0.496 ; 1.718 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 291 ; 7.898 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 120 ;26.939 ;19.717 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 317 ;12.731 ;15.189 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;17.225 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 286 ; 0.065 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2710 ; 0.002 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 451 ; 0.000 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 325 A 612 REMARK 3 ORIGIN FOR THE GROUP (A): 22.8930 61.5071 37.8679 REMARK 3 T TENSOR REMARK 3 T11: 0.0332 T22: 0.0060 REMARK 3 T33: 0.0359 T12: 0.0073 REMARK 3 T13: -0.0164 T23: 0.0017 REMARK 3 L TENSOR REMARK 3 L11: 2.0280 L22: 2.7529 REMARK 3 L33: 1.1274 L12: -0.3570 REMARK 3 L13: -0.5454 L23: 0.3496 REMARK 3 S TENSOR REMARK 3 S11: -0.0416 S12: -0.0476 S13: -0.0666 REMARK 3 S21: 0.1550 S22: 0.0415 S23: 0.1376 REMARK 3 S31: 0.0495 S32: 0.0214 S33: 0.0001 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 7P5P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1292117056. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-X REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54187 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26615 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 35.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.23000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.3M (NH4)2SO4 1M LI2SO4 0.1M PH=5.6 REMARK 280 NA3 CITRATE/HCL, PH 5.6, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 18.78633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.57267 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.17950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 46.96583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 9.39317 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 304 REMARK 465 GLY A 305 REMARK 465 SER A 306 REMARK 465 SER A 307 REMARK 465 HIS A 308 REMARK 465 HIS A 309 REMARK 465 HIS A 310 REMARK 465 HIS A 311 REMARK 465 HIS A 312 REMARK 465 HIS A 313 REMARK 465 SER A 314 REMARK 465 SER A 315 REMARK 465 GLY A 316 REMARK 465 LEU A 317 REMARK 465 VAL A 318 REMARK 465 PRO A 319 REMARK 465 ARG A 320 REMARK 465 GLY A 321 REMARK 465 PRO A 322 REMARK 465 LYS A 323 REMARK 465 VAL A 324 REMARK 465 CYS A 613 REMARK 465 ARG A 614 REMARK 465 LYS A 615 REMARK 465 GLN A 616 REMARK 465 ILE A 617 REMARK 465 ASP A 618 REMARK 465 GLN A 619 REMARK 465 GLN A 620 REMARK 465 ASN A 621 REMARK 465 CYS A 622 REMARK 465 THR A 623 REMARK 465 CYS A 624 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 336 -42.43 70.07 REMARK 500 HIS A 516 -126.33 59.52 REMARK 500 VAL A 547 -168.35 -117.09 REMARK 500 HIS A 575 -44.70 -142.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 326 0.08 SIDE CHAIN REMARK 500 ARG A 336 0.07 SIDE CHAIN REMARK 500 ARG A 354 0.08 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1134 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH A1135 DISTANCE = 6.23 ANGSTROMS DBREF 7P5P A 322 624 UNP Q9Z2X8 KEAP1_MOUSE 322 624 SEQADV 7P5P MET A 304 UNP Q9Z2X8 INITIATING METHIONINE SEQADV 7P5P GLY A 305 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P SER A 306 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P SER A 307 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 308 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 309 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 310 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 311 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 312 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P HIS A 313 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P SER A 314 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P SER A 315 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P GLY A 316 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P LEU A 317 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P VAL A 318 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P PRO A 319 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P ARG A 320 UNP Q9Z2X8 EXPRESSION TAG SEQADV 7P5P GLY A 321 UNP Q9Z2X8 EXPRESSION TAG SEQRES 1 A 321 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 321 LEU VAL PRO ARG GLY PRO LYS VAL GLY ARG LEU ILE TYR SEQRES 3 A 321 THR ALA GLY GLY TYR PHE ARG GLN SER LEU SER TYR LEU SEQRES 4 A 321 GLU ALA TYR ASN PRO SER ASN GLY SER TRP LEU ARG LEU SEQRES 5 A 321 ALA ASP LEU GLN VAL PRO ARG SER GLY LEU ALA GLY CYS SEQRES 6 A 321 VAL VAL GLY GLY LEU LEU TYR ALA VAL GLY GLY ARG ASN SEQRES 7 A 321 ASN SER PRO ASP GLY ASN THR ASP SER SER ALA LEU ASP SEQRES 8 A 321 CYS TYR ASN PRO MET THR ASN GLN TRP SER PRO CYS ALA SEQRES 9 A 321 SER MET SER VAL PRO ARG ASN ARG ILE GLY VAL GLY VAL SEQRES 10 A 321 ILE ASP GLY HIS ILE TYR ALA VAL GLY GLY SER HIS GLY SEQRES 11 A 321 CYS ILE HIS HIS SER SER VAL GLU ARG TYR GLU PRO GLU SEQRES 12 A 321 ARG ASP GLU TRP HIS LEU VAL ALA PRO MET LEU THR ARG SEQRES 13 A 321 ARG ILE GLY VAL GLY VAL ALA VAL LEU ASN ARG LEU LEU SEQRES 14 A 321 TYR ALA VAL GLY GLY PHE ASP GLY THR ASN ARG LEU ASN SEQRES 15 A 321 SER ALA GLU CYS TYR TYR PRO GLU ARG ASN GLU TRP ARG SEQRES 16 A 321 MET ILE THR PRO MET ASN THR ILE ARG SER GLY ALA GLY SEQRES 17 A 321 VAL CYS VAL LEU HIS ASN CYS ILE TYR ALA ALA GLY GLY SEQRES 18 A 321 TYR ASP GLY GLN ASP GLN LEU ASN SER VAL GLU ARG TYR SEQRES 19 A 321 ASP VAL GLU THR GLU THR TRP THR PHE VAL ALA PRO MET SEQRES 20 A 321 ARG HIS HIS ARG SER ALA LEU GLY ILE THR VAL HIS GLN SEQRES 21 A 321 GLY LYS ILE TYR VAL LEU GLY GLY TYR ASP GLY HIS THR SEQRES 22 A 321 PHE LEU ASP SER VAL GLU CYS TYR ASP PRO ASP SER ASP SEQRES 23 A 321 THR TRP SER GLU VAL THR ARG MET THR SER GLY ARG SER SEQRES 24 A 321 GLY VAL GLY VAL ALA VAL THR MET GLU PRO CYS ARG LYS SEQRES 25 A 321 GLN ILE ASP GLN GLN ASN CYS THR CYS HET CL A 701 1 HET SO4 A 702 5 HET 5RB A 703 73 HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM 5RB 5-[(1~{R},2~{R})-2-(1-METHYL-1,2,3-TRIAZOL-4-YL) HETNAM 2 5RB CYCLOPROPYL]-1-[3-[3-[(2~{R})-2-PROPYLPIPERIDIN-1- HETNAM 3 5RB YL]CARBONYLPHENYL]PHENYL]PYRAZOLE-4-CARBOXYLIC ACID FORMUL 2 CL CL 1- FORMUL 3 SO4 O4 S 2- FORMUL 4 5RB C31 H34 N6 O3 FORMUL 5 HOH *335(H2 O) HELIX 1 AA1 PRO A 492 ASN A 495 5 4 SHEET 1 AA1 4 TRP A 352 ARG A 354 0 SHEET 2 AA1 4 LEU A 342 TYR A 345 -1 N ALA A 344 O LEU A 353 SHEET 3 AA1 4 ARG A 326 ALA A 331 -1 N THR A 330 O GLU A 343 SHEET 4 AA1 4 GLY A 605 MET A 610 -1 O ALA A 607 N TYR A 329 SHEET 1 AA2 4 ALA A 366 VAL A 370 0 SHEET 2 AA2 4 LEU A 373 VAL A 377 -1 O TYR A 375 N CYS A 368 SHEET 3 AA2 4 LEU A 393 TYR A 396 -1 O TYR A 396 N LEU A 374 SHEET 4 AA2 4 TRP A 403 PRO A 405 -1 O SER A 404 N CYS A 395 SHEET 1 AA3 2 ARG A 380 SER A 383 0 SHEET 2 AA3 2 GLY A 386 ASP A 389 -1 O THR A 388 N ASN A 381 SHEET 1 AA4 4 GLY A 417 ILE A 421 0 SHEET 2 AA4 4 HIS A 424 VAL A 428 -1 O TYR A 426 N GLY A 419 SHEET 3 AA4 4 VAL A 440 TYR A 443 -1 O GLU A 441 N ALA A 427 SHEET 4 AA4 4 TRP A 450 VAL A 453 -1 O HIS A 451 N ARG A 442 SHEET 1 AA5 2 SER A 431 HIS A 432 0 SHEET 2 AA5 2 ILE A 435 HIS A 436 -1 O ILE A 435 N HIS A 432 SHEET 1 AA6 4 GLY A 464 LEU A 468 0 SHEET 2 AA6 4 LEU A 471 VAL A 475 -1 O VAL A 475 N GLY A 464 SHEET 3 AA6 4 ALA A 487 TYR A 491 -1 O TYR A 490 N LEU A 472 SHEET 4 AA6 4 GLU A 496 ILE A 500 -1 O ARG A 498 N CYS A 489 SHEET 1 AA7 4 GLY A 511 LEU A 515 0 SHEET 2 AA7 4 CYS A 518 ALA A 522 -1 O ALA A 522 N GLY A 511 SHEET 3 AA7 4 VAL A 534 ASP A 538 -1 O GLU A 535 N ALA A 521 SHEET 4 AA7 4 THR A 543 PHE A 546 -1 O THR A 545 N ARG A 536 SHEET 1 AA8 4 GLY A 558 HIS A 562 0 SHEET 2 AA8 4 LYS A 565 LEU A 569 -1 O TYR A 567 N THR A 560 SHEET 3 AA8 4 SER A 580 ASP A 585 -1 O TYR A 584 N ILE A 566 SHEET 4 AA8 4 THR A 590 ARG A 596 -1 O THR A 590 N ASP A 585 CRYST1 103.389 103.389 56.359 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009672 0.005584 0.000000 0.00000 SCALE2 0.000000 0.011169 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017743 0.00000